Adverse events and humoral response after two doses of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) mRNA vaccine in the hospital personnel of a cardiopulmonary tertiary-care center
- 15 July 2021
- journal article
- letter
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 43 (10) , 1532-1534
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Absence of Humoral Response After Two-Dose SARS-CoV-2 Messenger RNA Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: A Case SeriesAnnals of Internal Medicine, 2021
- Covid-19 vaccine acceptance, hesitancy, and refusal among Canadian healthcare workers: A multicenter surveyAmerican Journal of Infection Control, 2021
- Prevalence of COVID-19 Vaccine Side Effects among Healthcare Workers in the Czech RepublicJournal of Clinical Medicine, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineNew England Journal of Medicine, 2020
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City AreaJAMA, 2020